| Literature DB >> 35706523 |
Shila Haghighat1, Maryam Khosravi1, Mehrdad Rezaei1.
Abstract
Background: Carpal tunnel syndrome is a common condition that causes pain, sensory and motor symptoms in the hands, especially in the thumb, index, and middle fingers due to the compression of the median nerve in the carpal tunnel. The purpose of this research was to investigate the effect of the shock wave and phonophoresis in the improvement of clinical symptoms and function of patients with mild to moderate carpal tunnel syndrome.Entities:
Keywords: Carpal Tunnel Syndrome; Phonophoresis; Shock Wave
Year: 2021 PMID: 35706523 PMCID: PMC9167763 DOI: 10.47176/mjiri.35.179
Source DB: PubMed Journal: Med J Islam Repub Iran ISSN: 1016-1430
Fig. 1Summary of sample demographic information
| Investigated Parameter | Shock wave | Phonophoresis | Control | P value | |
|---|---|---|---|---|---|
| Gender | Female | 18 (30%) | 17 (27.5%) | 14 (25%) | 0.781* |
| Number(Percentage) | Male | 2(2.5%) | 3 (5%) | 6 (10%) | |
| Age (year) | M±SD | 50.10±8.14 | 50.05±5.99 | 51.13±9.06 | 0.113** |
* At the 5% level of Fisher's exact test
** At the 5% level of ANOVA test
Comparison of the mean of severity of symptoms and functional status of patients based on Boston scale by time, group therapy and side of patient body
| Investigated Parameter | Before | Within one month after the interventions | Within two months after the interventions |
P2
|
|
| |||
|---|---|---|---|---|---|---|---|---|---|
| Left BQ-SS* | Shock wave | 2.99±1.06 | 1.90±0.90 | 1.63±0.56 | 0.002 | 0.035 | <0.001 | ||
| Phonophoresis | 3.37±0.59 | 2.29±0.93 | 1.78±0.83 | <0.001 | |||||
| Control | 1.97±0.48 | 1.32±0.23 | 1.37±0.31 | 0.001 | |||||
| P1 | <0.001 | 0.008 | 0.243 | ||||||
| Right BQ-SS* | Shock wave | 3.71±0.66 | 1.99±0.58 | 1.97±0.55 | 0.001 | 0.006 | <0.001 | ||
| Phonophoresis | 3.18±0.63 | 2.23±0.67 | 1.83±0.68 | 0.001 | |||||
| Control | 1.91±0.71 | 1.07±0.13 | 1.37±0.63 | 0.013 | |||||
| P1 | <0.001 | <0.001 | 0.146 | ||||||
| Left BQ-FS** | Shock wave | 3.04±1.33 | 2.25±1.24 | 1.63±0.68 | <0.001 | 0.063 | 0.003 | ||
| Phonophoresis | 3.25±0.82 | 2.16±1.06 | 1.75±0.75 | 0.004 | |||||
| Control | 1.99±0.69 | 1.32±0.31 | 1.43±0.36 | 0.01 | |||||
| P1 | 0.004 | 0.003 | 0.418 | ||||||
| Right BQ-FS** | Shock wave | 3.62±1.07 | 2.57±0.55 | 2.36±0.68 | 0.034 | <0.001 | <0.001 | ||
| Phonophoresis | 3.13±0.82 | 2.38±0.84 | 1.90±0.73 | 0.010 | |||||
| Control | 1.99±0.56 | 1.18±0.36 | 1.43±0.56 | 0.021 | |||||
| P1 | 0.001 | <0.001 | 0.033 | ||||||
P1 at 5% level of Anova test
P2, p3, p4 at 5% level of Repeated Measures test
* Boston questionnaire severity status
** Boston questionnaire of functional status
Fig. 2Comparison of VAS score based on time, treatment group, and side of patient body
| Investigated Parameter | Before | 1 Month After | 2 Months after |
P2
|
P3
|
P4
| |
|---|---|---|---|---|---|---|---|
| Left. VAS | Shock wave | 4.28±3.35 | 4.42±2.5 | 1.14±0.69 | 0.021 | 0.231 | <0.001 |
| Phonophoresis | 6.50±2.41 | 3.10±2.51 | 2.50±3.27 | 0.056 | |||
| Control | 2.10±1.59 | 0.80±0.78 | 1.10±1.28 | 0.103 | |||
| P1 | 0.001 | 0.091 | 0.504 | ||||
| Right. VAS | Shock wave | 5.25±1.70 | 2.50±1.73 | 1.73±1.50 | 0.091 | 0.005 | <0.001 |
| Phonophoresis | 6.30±1.41 | 2.90±2.23 | 1.50±1.58 | 0.000 | |||
| Control | 2.09±1.97 | 0.81±1.07 | 0.63±0.92 | 0.057 | |||
| P1 | <0.001 | 0.027 | 0.138 | ||||
P1 at 5% level of Anova test
P2, p3, p4 at 5% level of Repeated Measures test